Ying Peng

2.4k total citations · 1 hit paper
28 papers, 1.7k citations indexed

About

Ying Peng is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ying Peng has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Ying Peng's work include Virus-based gene therapy research (4 papers), RNA Interference and Gene Delivery (3 papers) and TGF-β signaling in diseases (3 papers). Ying Peng is often cited by papers focused on Virus-based gene therapy research (4 papers), RNA Interference and Gene Delivery (3 papers) and TGF-β signaling in diseases (3 papers). Ying Peng collaborates with scholars based in China, United States and South Korea. Ying Peng's co-authors include Rex C. Haydon, Wei Jiang, Hue H. Luu, Tong‐Chuan He, Jung Tak Park, Hongwei Cheng, Quan Kang, J. Szatkowski, Naili An and Benjamin N. Breyer and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Bone and Joint Surgery.

In The Last Decade

Ying Peng

26 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)

2003 756 citations Hongwei Cheng, Wei Jiang et al. Journal of Bone and Joint Surgery profile →

Peers

Countries citing papers authored by Ying Peng

Since Specialization

Citations

This map shows the geographic impact of Ying Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Peng more than expected).

Fields of papers citing papers by Ying Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Peng. The network helps show where Ying Peng may publish in the future.

Co-authorship network of co-authors of Ying Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Peng. A scholar is included among the top collaborators of Ying Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Peng. Ying Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stage-specific and cell-autonomous functions of Delta-like 1 in skeletal muscle stem cells and myogenesis 2025 ·Nature Communications ·Ying Peng, (unknown), (unknown), Haowei Xu, (unknown), Stephanie N. Oprescu, Feng Yue, Jingjuan Chen, Shihuan Kuang	0
2	Gastrointestinal adverse events associated with SNRIs: A FAERS-based pharmacovigilance study 2025 ·Journal of Affective Disorders ·Jiayi Lin, Sijia Wei, Ying Peng, (unknown), Jiao Wang, (unknown), (unknown), Fengxia Yan, (unknown)	1
3	Glutamate activates the MAPK pathway by inhibiting LPAR1 expression and promotes anlotinib resistance in thyroid cancer 2025 ·Discover Oncology ·Bin Liu, Ying Peng, Yanjun Su, (unknown), (unknown), (unknown)	1
4	Factors influencing the quality of life in survivors of differentiated thyroid cancer based on patient-reported outcomes: a single-center cross-sectional study 2025 ·Frontiers in Endocrinology ·Zhizhong Dong, (unknown), Wen Liu, Dewei Rao, Yang Miao, Ying Peng, Yanjun Su, (unknown)	0
5	Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center 2024 ·Endocrine ·Bin Liu, Ying Peng, Yanjun Su, (unknown), Ruochuan Cheng	2
6	Trastuzumab plus pertuzumab in combination with chemotherapy in metastatic HER2-positive breast cancer: a retrospective single-armed cohort study in China 2022 ·Annals of Translational Medicine ·Qian Yu, Ying Peng, Hao Zhou, Lili Zhang, Yuan Yuan	3
7	Validation of Stable Housekeeping Genes for Quantitative Real Time PCR in Golden Syrian Hamster 2020 ·Indian Journal of Animal Research ·Jinxin Miao, (unknown), (unknown), Haoran Guo, (unknown), Ying Peng, Yachao Wang, (unknown), Xiu-Min Li	6
8	Engineering improved thermostability of the GH11 xylanase from Neocallimastix patriciarum via computational library design 2018 ·Applied Microbiology and Biotechnology ·Yifan Bu, Yinglu Cui, Ying Peng, Meirong Hu, Yue Tian, Yong Tao, Bian Wu	47
9	Efficient induction of cross-presentating human B cell by transduction with human adenovirus type 7 vector 2015 ·Immunology Letters ·Ying Peng, (unknown), (unknown), Yanqing Liu, Huiyan Wang, Xiaoqun Zheng	2
10	The protamine-like DNA-binding protein P6.9 epigenetically up-regulates Autographa californica multiple nucleopolyhedrovirus gene transcription in the late infection phase 2012 ·Virologica Sinica ·Ying Peng, Kun Li, Rongjuan Pei, Chunchen Wu, Changyong Liang, Yun Wang, Xinwen Chen	6
11	Synthesis and Tunable Luminescent Properties of Red Phosphor Li _{1− m} Ag _m La _{0.99− n} Y _n Pr _0.01 ( MoO ₄ ) ₂ with Blue Excitation for White LED s 2011 ·Journal of the American Ceramic Society ·(unknown), Jie Liu, Chao Song, Hui Luo, Ying Peng, Xinbin Yu	12
12	shRNA driven by Pol II/T7 dual-promoter system effectively induce cell-specific RNA interference in mammalian cells 2007 ·Biochemical and Biophysical Research Communications ·Ying Peng, Jianxin Lü, (unknown)	10
13	The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells 2007 ·Journal of Biotechnology ·Ying Peng, Jianhua Song, Jianxin Lü, Xinwen Chen	13
14	Gene Therapy for Bone Regeneration 2005 ·Current Gene Therapy ·Jeffrey Luo, (unknown), Quan Kang, Ying Peng, Wei Jiang, Hue H. Luu, Qing Luo, Jae Ho Park, (unknown), Rex C. Haydon	68
15	Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets 2004 ·Current Cancer Drug Targets ·Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth R. Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang, Tong‐Chuan He	184
16	Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells 2004 ·Journal of Biological Chemistry ·Ying Peng, Quan Kang, Qing Luo, Wei Jiang, Weike Si, Bernard A. Liu, Hue H. Luu, Jong Kyung Park, Xinmin Li, Jeffrey Luo, Anthony Montag, Rex C. Haydon, Tong‐Chuan He	152
17	OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS) breakdown → 2003 ·Journal of Bone and Joint Surgery ·Hongwei Cheng, Wei Jiang, Frank M. Phillips, Rex C. Haydon, Ying Peng, Lan Zhou, Hue H. Luu, Naili An, Benjamin N. Breyer, (unknown), J. Szatkowski, Jung Tak Park, Tong‐Chuan He	756
18	Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling 2003 ·Journal of Cellular Biochemistry ·Ying Peng, Quan Kang, Hongwei Cheng, Xinmin Li, (unknown), Wei Jiang, Hue H. Luu, Jung Tak Park, Rex C. Haydon, Tong‐Chuan He	124
19	Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity 2003 ·Cancer Letters ·Lan Zhou, Naili An, Rex C. Haydon, Qixin Zhou, Hongwei Cheng, Ying Peng, Wei Jiang, Hue H. Luu, (unknown), J. Szatkowski, Jung Tak Park, Benjamin N. Breyer, Tong‐Chuan He	68
20	Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA 2003 ·Movement Disorders ·Ying Peng, Roger L. Crumley, John M. Ringman	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact